930837-03-9Relevant articles and documents
IMIDAZOPYRAZINE SYK INHIBITORS
-
Paragraph 0440, (2014/01/08)
Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suf-fering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of an imidazopyrazine compound effective to reduce signs or symptoms of the disease or dis-order are provided.
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
-
Page/Page column 19, (2010/11/26)
The present invention is directed to compounds having the formula (I), and/or pharmaceutically-acceptable salts thereof, useful in the treatment of androgen-receptor associated conditions, wherein Ar is aryl, substituted aryl, heteroaryl, or substituted heteroaryl; L is a linker as defined in the specification; R1 may be hydrogen, cyano, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, heterocyclo, substituted heterocyclo, heteroaryl, or substituted heteroaryl, as defined in the specification; R2 is hydrogen, lower alkyl, or substituted lower alkyl; and R3, R4 and R5 are optionally non-interfering substituents as defined in the specification.
OXAZOLIDINONE ANTIBACTERIAL AGENT WITH TRICYCLIC SUBSTITUENTS
-
Page 11, (2010/02/06)
This invention provides novel oxazolidinone derivatives represented by chemical formula (I), or pharmaceutically acceptable salts thereof: wherein X is NR1, CR2R3, O, S, SO, or SO2; and Z is NR4, S, SO, SO2 or O. The compounds are useful antimicrobial age
Oxazolidinone antibacterial agent with tricyclic substituents
-
, (2008/06/13)
This invention provides novel oxazolidinone derivatives represented by chemical Formula (I), or pharmaceutically acceptable salts thereof: STR1 wherein X is NR1, CR2 R3, O, S, SO, or SO2 ; and Z is NR4/sub